|Dr. Bernard Tuch BSc, FRACP, GAICD, MBBS (Hons), Ph.D.||Exec. Chairman & Interim CEO||47.1k||N/A||1951|
|Mr. Daya Uka||Chief Financial Officer||105.62k||N/A||N/A|
|Dr. Belinda Di Bartolo||Chief Operating Officer||N/A||N/A||N/A|
|Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP||Company Sec.||N/A||N/A||1964|
Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia.
Living Cell Technologies Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.